Thymosin

Thymosin has been studied in 1 paper since 1989: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 29, 2026: “Regarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression”.

Intervention

1 paper studies it52 more mention it2 findingsUpdated

PubChemMeSH

More peptides

  • 1 lab in 1 country
  • Funder: Japan Society for the Promotion of Science
  • Animals1

What did studies of Thymosin find?

2

Studies of Thymosin measured 2 outcomes; the most studied are kidney disease (1 study) and lifespan (1).

Kidney disease

downin mice1

1 study
  1. Thymosin protects against kidney disease in mice.

    “administration of thymosin in B/WF1 mice resulted in amelioration of kidney disease and elongation of the mean life span.”

    Animalsin autoimmune prone B/WF1 mice

    Combined grafting of bone marrow and thymus, and sequential multiple thymus graftings in various strains of mice. The effect on immune functions and life span

    Mechanisms of ageing and development

More on Kidney disease

Lifespan

upin mice1

1 study
  1. Thymosin extends lifespan in mice.

    “administration of thymosin in B/WF1 mice resulted in amelioration of kidney disease and elongation of the mean life span.”

    Animalsin autoimmune prone B/WF1 mice

    Combined grafting of bone marrow and thymus, and sequential multiple thymus graftings in various strains of mice. The effect on immune functions and life span

    Mechanisms of ageing and development

Latest

Nov 2025: 2Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 1Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 05 papers in 12 months